Ali B H, Al-Moundhri M, Eldin M Tag, Nemmar A, Al-Siyabi S, Annamalai K
Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, PO Box 35, Al Khod, Postal code 123, Oman.
Exp Biol Med (Maywood). 2008 Jul;233(7):891-6. doi: 10.3181/0711-RM-315. Epub 2008 Apr 29.
Nephrotoxicity of the anticancer drug, cisplatin (CP) involves enhanced renal generation of reactive oxygen metabolites and lipid peroxidation caused by decreased levels of antioxidants and antioxidant enzymes. Tetramethylpyrazine (TMP) is known to act as a strong antioxidant. Therefore, in the present work, we aimed at testing the possible protective or palliative effect of TMP on CP nephrotoxicity in rats. TMP was given orally at a dose of 80 mg . kg(- 1) . day(- 1) for 7 days. Some of these rats were given a single intraperitoneal injection of CP (or vehicle) at a dose of 6 mg/kg on Day 6 of treatment. Animals were sacrificed 6 days after CP (or vehicle) treatment, and blood, urine, and kidneys were obtained. Nephrotoxicity was assessed biochemically by measuring creatinine and urea in serum, reduced glutathione (GSH) concentration in renal cortex, by urinalysis, and histopathologically by light microscopy. CP significantly increased the concentration of urea and creatinine (P < 0.05) by about 128% and 170%, respectively; increased urine volume and N-acetyl-beta-D-glucosaminidase (NAG) activity; and significantly decreased osmolality and protein concentrations. CP treatment reduced GSH by about 34% (P < 0.05) and superoxide dismutase (SOD) and total antioxidant activity (TOX) by about 28% and 21%, respectively (P < 0.05). TMP pretreatment significantly mitigated all of these effects. Sections from saline- and TMP-treated rats showed apparently normal proximal tubules. However, kidneys of CP-treated rats had a moderate degree of necrosis. This was markedly reduced when CP was given after pretreatment with TMP. CP cortical concentration was not significantly altered by TMP treatment. The results suggest that TMP ameliorated the histological, physiological, and biochemical indices of nephrotoxicity in rats. Pending further pharmacological and toxicological studies, TMP may potentially be useful as a nephroprotective agent.
抗癌药物顺铂(CP)的肾毒性涉及肾脏中活性氧代谢产物生成增加以及抗氧化剂和抗氧化酶水平降低导致的脂质过氧化。已知川芎嗪(TMP)具有强大的抗氧化作用。因此,在本研究中,我们旨在测试TMP对大鼠CP肾毒性可能的保护或缓解作用。TMP以80 mg·kg⁻¹·d⁻¹的剂量口服给药7天。在治疗的第6天,其中一些大鼠接受一次腹腔注射剂量为6 mg/kg的CP(或溶剂)。在CP(或溶剂)治疗6天后处死动物,获取血液、尿液和肾脏。通过测量血清中的肌酐和尿素、肾皮质中还原型谷胱甘肽(GSH)浓度进行生化评估肾毒性,通过尿液分析,并通过光学显微镜进行组织病理学评估。CP使尿素和肌酐浓度分别显著增加约128%和170%(P < 0.05);增加尿量和N - 乙酰 - β - D - 氨基葡萄糖苷酶(NAG)活性;并显著降低渗透压和蛋白质浓度。CP治疗使GSH降低约34%(P < 0.05),超氧化物歧化酶(SOD)和总抗氧化活性(TOX)分别降低约28%和21%(P < 0.05)。TMP预处理显著减轻了所有这些影响。生理盐水和TMP处理大鼠的切片显示近端小管明显正常。然而,CP处理大鼠的肾脏有中度坏死。当CP在TMP预处理后给药时,这种坏死明显减少。TMP处理未显著改变CP在皮质中的浓度。结果表明,TMP改善了大鼠肾毒性的组织学、生理学和生化指标。在进一步的药理学和毒理学研究之前,TMP可能有潜力作为一种肾保护剂。